Last mentioned: Mar 20, 2026
Commercial Scalability Assessment
Evaluation of bio-foundry partnerships to standardize the production of engineered scaffolds.
Regulatory Submission
Expected filing for Advanced Therapy Medicinal Product (ATMP) designation with the MHRA.
Expanded Clinical Trials
Anticipated start of Phase II trials involving a larger cohort of pediatric patients with long-gap OA.
Breakthrough Announcement
First successful lab-grown oesophagus for pediatric use is unveiled to the public.
Researchers have successfully engineered the first lab-grown oesophagus, providing a transformative solution for children born with Oesophageal Atresia. This tissue-engineered breakthrough uses a patient's own cells to create a functional organ, potentially eliminating the need for high-risk invasive surgeries.